Loading organizations...
Key people at JW Asset Management.
JW Asset Management was founded in 2003 by Jason Wild (Founder, President & Chief Investment Officer).
JW Asset Management is an SEC-registered investment adviser that manages private funds focused on long-term investments in undervalued companies, primarily within the healthcare, pharmaceutical, and cannabis sectors. The firm provides discretionary investment management services to funds such as JW Partners, LP and JW Opportunities Fund, overseeing more than $300 million in assets under management. JW Partners, LP has demonstrated a 27.31% annual net return since 1999 as of August 2018. Known for its active role in the cannabis sector since 2014, JW Asset Management has invested in prominent companies including Canopy Growth, Cronos Group, and TerrAscend Corp. The leadership team features Jason Wild as President and Chief Investment Officer, Jason Klarreich as Chief Operating Officer, and Michelle Maranto on the senior team. The firm was established in November 2003 by Jason Wild.
Key people at JW Asset Management.
JW Asset Management was founded in 2003 by Jason Wild (Founder, President & Chief Investment Officer).
JW Asset Management has 6 tracked investments across 5 companies. The latest tracked deal is $7.5M Series A in Allumia in February 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 8, 2022 | Allumia | $7.5M Series A | JW Asset Management | American Electric Power, Duke Investments |
| Nov 8, 2021 | Fyllo | $40.0M Series C | Kristopher Koka | Arcadian Capital Management, ArrowMark Partners, K2 Asset Management, Longview Capital Advisors, Phyto Partners, Salveo Capital |
| Aug 12, 2020 | Fyllo | $10.0M Series A | JW Asset Management, K2 & Associates | Arcadian Capital Management, Phyto Partners, Salveo Capital |
| Sep 10, 2019 | Canndescent | $27.5M Series C | Tyler Stuart | Altitude Investment Management, Carnegie Arch Capital, Senterra |
| Aug 8, 2019 | Henry's Originals | $11.0M Series B | Mina Mishrikey | BIG Rock Partners, Delta Emerald Ventures |
| Nov 12, 2010 | Arbor Pharmaceuticals | $34.8M Debt / Series B | Signet Healthcare Partners | Arch Healthcare Fund |
